| Year |
Citation |
Score |
| 2021 |
McClure EA, Wahlquist AE, Tomko RL, Baker NL, Carpenter MJ, Bradley ED, Cato PA, Gipson CD, Gray KM. Evaluating N-acetylcysteine for early and end-of-treatment abstinence in adult cigarette smokers. Drug and Alcohol Dependence. 225: 108815. PMID 34171822 DOI: 10.1016/j.drugalcdep.2021.108815 |
0.308 |
|
| 2020 |
Baker NL, Gray KM, Ramakrishnan V, Tomko RL, McClure EA, Carpenter MJ, Saladin ME. Increases in endogenous progesterone attenuate smoking in a cohort of nontreatment seeking women: An exploratory prospective study. Addiction Biology. e12918. PMID 32476209 DOI: 10.1111/Adb.12918 |
0.315 |
|
| 2020 |
Carpenter RW, Squeglia LM, Emery NN, McClure EA, Gray KM, Miranda R, Tomko RL. Making pharmacotherapy trials for substance use disorder more efficient: Leveraging real-world data capture to maximize power and expedite the medication development pipeline. Drug and Alcohol Dependence. 209: 107897. PMID 32058245 DOI: 10.1016/J.Drugalcdep.2020.107897 |
0.341 |
|
| 2019 |
Aguinaldo LD, Squeglia LM, Gray KM, Coronado C, Lees B, Tomko RL, Jacobus J. Behavioral Treatments for Adolescent Cannabis Use Disorder: a Rationale for Cognitive Retraining. Current Addiction Reports. 6: 437-442. PMID 32257767 DOI: 10.1007/S40429-019-00287-7 |
0.39 |
|
| 2019 |
Tomko RL, Gray KM, Huestis MA, Squeglia LM, Baker NL, McClure EA. Measuring Within-Individual Cannabis Reduction in Clinical Trials: A Review of the Methodological Challenges. Current Addiction Reports. 6: 429-436. PMID 32133273 DOI: 10.1007/S40429-019-00290-Y |
0.334 |
|
| 2019 |
Tomko RL, Baker NL, Hood CO, Gilmore AK, McClure EA, Squeglia LM, McRae-Clark AL, Sonne SC, Gray KM. Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder. Psychopharmacology. PMID 31712969 DOI: 10.1007/S00213-019-05384-Z |
0.434 |
|
| 2019 |
McClure EA, Baker NL, Hood CO, Tomko RL, Squeglia LM, Flanagan JC, Carpenter MJ, Gray KM. Cannabis and Alcohol Co-Use in a Smoking Cessation Pharmacotherapy Trial for Adolescents and Emerging Adults. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 31612956 DOI: 10.1093/Ntr/Ntz170 |
0.364 |
|
| 2019 |
Gray KM, Baker NL, McClure EA, Tomko RL, Squeglia LM, Saladin ME, Carpenter MJ. Efficacy and Safety of Varenicline for Adolescent Smoking Cessation: A Randomized Clinical Trial. Jama Pediatrics. PMID 31609433 DOI: 10.1001/Jamapediatrics.2019.3553 |
0.315 |
|
| 2019 |
Fadus MC, Squeglia LM, Valadez EA, Tomko RL, Bryant BE, Gray KM. Adolescent Substance Use Disorder Treatment: an Update on Evidence-Based Strategies. Current Psychiatry Reports. 21: 96. PMID 31522280 DOI: 10.1007/S11920-019-1086-0 |
0.389 |
|
| 2019 |
Tomko RL, McClure EA, Cato PA, Wang JB, Carpenter MJ, Karelitz JL, Froeliger B, Saladin ME, Gray KM. An electronic, smart lighter to measure cigarette smoking: A pilot study to assess feasibility and initial validity. Addictive Behaviors. 98: 106052. PMID 31415971 DOI: 10.1016/J.Addbeh.2019.106052 |
0.317 |
|
| 2019 |
Squeglia LM, Fadus MC, McClure EA, Tomko RL, Gray KM. Pharmacological Treatment of Youth Substance Use Disorders. Journal of Child and Adolescent Psychopharmacology. PMID 31009234 DOI: 10.1089/Cap.2019.0009 |
0.431 |
|
| 2019 |
Montgomery L, McClure EA, Tomko RL, Sonne SC, Winhusen T, Terry GE, Grossman JT, Gray KM. Blunts versus joints: Cannabis use characteristics and consequences among treatment-seeking adults. Drug and Alcohol Dependence. 198: 105-111. PMID 30901744 DOI: 10.1016/J.Drugalcdep.2019.01.041 |
0.342 |
|
| 2019 |
Tomko RL, McClure EA, Squeglia LM, Treloar Padovano H, McRae-Clark AL, Baker NL, Carpenter MJ, Gray KM. Methods to reduce the incidence of false negative trial results in substance use treatment research. Current Opinion in Psychology. 30: 35-41. PMID 30798020 DOI: 10.1016/J.Copsyc.2019.01.009 |
0.351 |
|
| 2019 |
Akbar SA, Tomko RL, Salazar CA, Squeglia LM, McClure EA. Tobacco and cannabis co-use and interrelatedness among adults. Addictive Behaviors. 90: 354-361. PMID 30522075 DOI: 10.1016/J.Addbeh.2018.11.036 |
0.35 |
|
| 2018 |
McClure EA, Tomko RL, Salazar CA, Akbar SA, Squeglia LM, Herrmann E, Carpenter MJ, Peters EN. Tobacco and cannabis co-use: Drug substitution, quit interest, and cessation preferences. Experimental and Clinical Psychopharmacology. PMID 30556733 DOI: 10.1037/Pha0000244 |
0.354 |
|
| 2018 |
Tomko RL, Gilmore AK, Gray KM. Corrigendum to The role of depressive symptoms in treatment of adolescent cannabis use disorder with N-Acetylcysteine Addictive Behaviors 85 (2018) 26-30. Addictive Behaviors. PMID 30268706 DOI: 10.1016/J.Addbeh.2018.09.023 |
0.399 |
|
| 2018 |
McClure EA, Baker NL, Sonne SC, Ghitza UE, Tomko RL, Montgomery L, Babalonis S, Terry GE, Gray KM. Tobacco use during cannabis cessation: Use patterns and impact on abstinence in a National Drug Abuse Treatment Clinical Trials Network study. Drug and Alcohol Dependence. 192: 59-66. PMID 30218864 DOI: 10.1016/J.Drugalcdep.2018.07.018 |
0.343 |
|
| 2018 |
Tomko RL, Jones JL, Gilmore AK, Brady KT, Back SE, Gray KM. -acetylcysteine: A potential treatment for substance use disorders. Current Psychiatry. 17: 30-55. PMID 30016376 |
0.317 |
|
| 2018 |
Sahlem GL, Tomko RL, Sherman BJ, Gray KM, McRae-Clark AL. Impact of cannabis legalization on treatment and research priorities for cannabis use disorder. International Review of Psychiatry (Abingdon, England). 1-10. PMID 29956576 DOI: 10.1080/09540261.2018.1465398 |
0.333 |
|
| 2018 |
Bountress KE, Bacanu SA, Tomko RL, Korte KJ, Hicks T, Sheerin C, Lind MJ, Marraccini M, Nugent N, Amstadter AB. The Effects of a BDNF Val66Met Polymorphism on Posttraumatic Stress Disorder: A Meta-Analysis. Neuropsychobiology. 1-7. PMID 29874672 DOI: 10.1159/000489407 |
0.326 |
|
| 2018 |
Tomko RL, Gilmore AK, Gray KM. The role of depressive symptoms in treatment of adolescent cannabis use disorder with N-Acetylcysteine. Addictive Behaviors. 85: 26-30. PMID 29803870 DOI: 10.1016/J.Addbeh.2018.05.014 |
0.333 |
|
| 2018 |
Tomko RL, McClure EA. Introduction to the special issue: Utilizing ambulatory assessment to better understand the etiology, maintenance, treatment, and remission of addictive disorders. Addictive Behaviors. PMID 29661656 DOI: 10.1016/J.Addbeh.2018.04.004 |
0.399 |
|
| 2018 |
Tomko RL, Gray KM, Oppenheimer SR, Wahlquist AE, McClure EA. Using REDCap for ambulatory assessment: Implementation in a clinical trial for smoking cessation to augment in-person data collection. The American Journal of Drug and Alcohol Abuse. 1-16. PMID 29513609 DOI: 10.1080/00952990.2018.1437445 |
0.324 |
|
| 2018 |
Squeglia LM, Tomko RL, Baker NL, McClure EA, Book GA, Gray KM. The effect of N-acetylcysteine on alcohol use during a cannabis cessation trial. Drug and Alcohol Dependence. 185: 17-22. PMID 29413434 DOI: 10.1016/J.Drugalcdep.2017.12.005 |
0.427 |
|
| 2017 |
Gray KM, Sonne SC, McClure EA, Ghitza UE, Matthews AG, McRae-Clark AL, Carroll KM, Potter JS, Wiest K, Mooney LJ, Hasson A, Walsh SL, Lofwall MR, Babalonis S, Lindblad RW, ... ... Tomko RL, et al. A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults. Drug and Alcohol Dependence. 177: 249-257. PMID 28623823 DOI: 10.1016/J.Drugalcdep.2017.04.020 |
0.378 |
|
| 2017 |
Clayton RB, Leshner G, Tomko RL, Trull TJ, Piasecki TM. Countering Craving with Disgust Images: Examining Nicotine Withdrawn Smokers' Motivated Message Processing of Anti-Tobacco Public Service Announcements. Journal of Health Communication. 22: 254-261. PMID 28248620 DOI: 10.1080/10810730.2016.1268222 |
0.522 |
|
| 2017 |
Korte KJ, Bountress KE, Tomko RL, Killeen T, Moran-Santa Maria M, Back SE. Integrated Treatment of PTSD and Substance Use Disorders: The Mediating Role of PTSD Improvement in the Reduction of Depression. Journal of Clinical Medicine. 6. PMID 28098747 DOI: 10.3390/Jcm6010009 |
0.413 |
|
| 2016 |
Tomko RL, Saladin ME, McClure EA, Squeglia LM, Carpenter MJ, Tiffany ST, Baker NL, Gray KM. Alcohol consumption as a predictor of reactivity to smoking and stress cues presented in the natural environment of smokers. Psychopharmacology. PMID 27838746 DOI: 10.1007/S00213-016-4472-X |
0.325 |
|
| 2016 |
Squeglia LM, Baker NL, McClure EA, Tomko RL, Adisetiyo V, Gray KM. Alcohol use during a trial of N-acetylcysteine for adolescent marijuana cessation. Addictive Behaviors. 63: 172-177. PMID 27521979 DOI: 10.1016/J.Addbeh.2016.08.001 |
0.342 |
|
| 2016 |
Tomko RL, Bountress KE, Gray KM. Personalizing substance use treatment based on pre-treatment impulsivity and sensation seeking: A review. Drug and Alcohol Dependence. PMID 27515725 DOI: 10.1016/J.Drugalcdep.2016.07.022 |
0.359 |
|
| 2016 |
Tomko RL, Prisciandaro JJ, Falls SK, Magid V. The structure of the UPPS-R-Child impulsivity scale and its relations with substance use outcomes among treatment-seeking adolescents. Drug and Alcohol Dependence. PMID 26905208 DOI: 10.1016/J.Drugalcdep.2016.02.010 |
0.32 |
|
| 2016 |
Scheiderer EM, Wang T, Tomko RL, Wood PK, Trull TJ. Negative Affect Instability among Individuals with Comorbid Borderline Personality Disorder and Posttraumatic Stress Disorder. Clinical Psychological Science : a Journal of the Association For Psychological Science. 4: 67-81. PMID 26904388 DOI: 10.1177/2167702615573214 |
0.614 |
|
| 2015 |
Bentzley JP, Tomko RL, Gray KM. Low Pretreatment Impulsivity and High Medication Adherence Increase the Odds of Abstinence in a Trial of N-Acetylcysteine in Adolescents with Cannabis Use Disorder. Journal of Substance Abuse Treatment. PMID 26827257 DOI: 10.1016/J.Jsat.2015.12.003 |
0.388 |
|
| 2015 |
Tomko RL, Lane SP, Pronove LM, Treloar HR, Brown WC, Solhan MB, Wood PK, Trull TJ. Undifferentiated Negative Affect and Impulsivity in Borderline Personality and Depressive Disorders: A Momentary Perspective. Journal of Abnormal Psychology. PMID 26147324 DOI: 10.1037/Abn0000064 |
0.595 |
|
| 2015 |
Tomko RL, Lane SP, Pronove LM, Treloar HR, Brown WC, Solhan MB, Wood PK, Trull TJ. Undifferentiated Negative Affect and Impulsivity in Borderline Personality and Depressive Disorders: A Momentary Perspective Journal of Abnormal Psychology. DOI: 10.1037/abn0000064 |
0.567 |
|
| 2014 |
Tomko RL, Trull TJ, Wood PK, Sher KJ. Characteristics of borderline personality disorder in a community sample: comorbidity, treatment utilization, and general functioning. Journal of Personality Disorders. 28: 734-50. PMID 25248122 DOI: 10.1521/Pedi_2012_26_093 |
0.628 |
|
| 2014 |
Epler AJ, Tomko RL, Piasecki TM, Wood PK, Sher KJ, Shiffman S, Heath AC. Does hangover influence the time to next drink? An investigation using ecological momentary assessment. Alcoholism, Clinical and Experimental Research. 38: 1461-9. PMID 24588377 DOI: 10.1111/Acer.12386 |
0.326 |
|
| 2014 |
Tomko RL, Solhan MB, Carpenter RW, Brown WC, Jahng S, Wood PK, Trull TJ. Measuring impulsivity in daily life: the momentary impulsivity scale. Psychological Assessment. 26: 339-49. PMID 24274047 DOI: 10.1037/A0035083 |
0.583 |
|
| 2014 |
Brown WC, Tragesser SL, Tomko RL, Mehl MR, Trull TJ. Recall of expressed affect during naturalistically observed interpersonal events in those with borderline personality disorder or depressive disorder. Assessment. 21: 73-81. PMID 24056953 DOI: 10.1177/1073191113504618 |
0.606 |
|
| 2014 |
Tomko RL, Brown WC, Tragesser SL, Wood PK, Mehl MR, Trull TJ. Social context of anger in borderline personality disorder and depressive disorders: findings from a naturalistic observation study. Journal of Personality Disorders. 28: 434-48. PMID 22984859 DOI: 10.1521/Pedi_2012_26_064 |
0.614 |
|
| 2013 |
Carpenter RW, Tomko RL, Trull TJ, Boomsma DI. Gene-environment studies and borderline personality disorder: a review. Current Psychiatry Reports. 15: 336. PMID 23250817 DOI: 10.1007/S11920-012-0336-1 |
0.577 |
|
| 2011 |
Jahng S, Solhan MB, Tomko RL, Wood PK, Piasecki TM, Trull TJ. Affect and alcohol use: an ecological momentary assessment study of outpatients with borderline personality disorder. Journal of Abnormal Psychology. 120: 572-84. PMID 21823761 DOI: 10.1037/A0024686 |
0.603 |
|
| 2011 |
Jahng S, Trull TJ, Wood PK, Tragesser SL, Tomko R, Grant JD, Bucholz KK, Sher KJ. Distinguishing general and specific personality disorder features and implications for substance dependence comorbidity. Journal of Abnormal Psychology. 120: 656-69. PMID 21604829 DOI: 10.1037/A0023539 |
0.576 |
|
| 2011 |
Talley AE, Tomko RL, Littlefield AK, Trull TJ, Sher KJ. The influence of general identity disturbance on reports of lifetime substance use disorders and related outcomes among sexual minority adults with a history of substance use. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. 25: 530-41. PMID 21480677 DOI: 10.1037/A0023022 |
0.533 |
|
| 2010 |
Trull TJ, Jahng S, Tomko RL, Wood PK, Sher KJ. Revised NESARC personality disorder diagnoses: gender, prevalence, and comorbidity with substance dependence disorders. Journal of Personality Disorders. 24: 412-26. PMID 20695803 DOI: 10.1521/Pedi.2010.24.4.412 |
0.596 |
|
| 2010 |
Tragesser SL, Solhan M, Brown WC, Tomko RL, Bagge C, Trull TJ. Longitudinal associations in borderline personality disorder features: Diagnostic Interview for Borderlines-Revised (DIB-R) scores over time. Journal of Personality Disorders. 24: 377-91. PMID 20545501 DOI: 10.1521/Pedi.2010.24.3.377 |
0.528 |
|
| 2010 |
Trull TJ, Tomko RL, Brown WC, Scheiderer EM. Borderline Personality Disorder in 3-D: Dimensions, Symptoms, and Measurement Challenges Social and Personality Psychology Compass. 4: 1057-1069. DOI: 10.1111/J.1751-9004.2010.00312.X |
0.419 |
|
| Show low-probability matches. |